ETA
LIVE

Serial Number

79334978

Owner

AceMedic Inc.

Attorney

Boris Umansky

Filing Date

Dec 20, 2021

Add to watchlist:

No watchlists yet
View on USPTO

ETA Trademark

Serial Number: 79334978 • Registration: 7178304

ETA is a trademark filed by AceMedic Inc. on December 20, 2021. The trademark is classified under Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

AceMedic Inc. (3 trademarks)

3-65, Kitanagasehonmachi,

Entity Type: 03

Trademark Details

Filing Date

December 20, 2021

Registration Date

October 3, 2023

Published for Opposition

July 18, 2023

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Jan 30, 2024 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jan 5, 2024 FICS
FINAL DISPOSITION PROCESSED
Jan 5, 2024 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jan 3, 2024 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Oct 3, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Oct 3, 2023 R.PR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Aug 27, 2023 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Aug 9, 2023 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Aug 9, 2023 OPNR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 18, 2023 NPUB
PUBLISHED FOR OPPOSITION
Jul 18, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 28, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 15, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 14, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 13, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 13, 2023 TROA
REFUSAL PROCESSED BY IB
Jan 9, 2023 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Dec 17, 2022 RFCS
REFUSAL PROCESSED BY MPU
Dec 17, 2022 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Oct 7, 2022 RFCR
NON-FINAL ACTION WRITTEN
Oct 6, 2022 CNRT
ASSIGNED TO EXAMINER
Sep 26, 2022 DOCK
APPLICATION FILING RECEIPT MAILED
Mar 8, 2022 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 4, 2022 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Mar 3, 2022 REPR